How to manage Candida auris infection in a central line?

Hello,

Welcome to icliniq.com.

I can understand your concern.

Candida auris is a serious fungal infection, especially in hospitalized patients with central lines. Removing or replacing the catheter is often necessary because the fungus can form biofilms (layers) on the line that antifungal medicines alone cannot fully clear. If the catheter remains, it can continue to cause infection despite treatment. To monitor whether antifungals are working, doctors check blood cultures regularly. If they stay positive or the fever persists, it might mean the treatment needs adjustment.

Important questions to ask the care team include:

1. What antifungal medication is being used?

2. Are blood cultures being repeated daily?

3. Is there a need for additional imaging (like an echocardiogram) to rule out fungal spread to the heart (endocarditis)?

4. Early and aggressive management is critical to avoid complications like septic shock.

Stay closely involved with the team and ask for regular updates on blood work and cultures.

The Probable causes:

1. Central venous catheter colonization.

2. Immunosuppression due to pneumonia and hospitalization. Possible nosocomial (hospital-acquired) infection.

Investigations to be done:

1. Repeated blood cultures (every 24 to 48 hours).

2. Sensitivity testing of Candida auris to guide antifungal therapy.

3. Complete blood count (CBC).

4. Kidney and liver function tests (to monitor antifungal toxicity).

5. Echocardiogram to rule out endocarditis.

6. Imaging (CT/MRI) if a localized infection or deep organ involvement is suspected.

Differential diagnosis:

1. Bacterial catheter-related bloodstream infection.

2. Other fungal infections (Candida albicans, Candida tropicalis).

3. Viral infections cause persistent fever.

Probable diagnosis:

1. Candida auris bloodstream infection is secondary to an infected central venous catheter.

Treatment plan:

1. Immediate removal and replacement of the infected central line.

2. Initiation of appropriate antifungal therapy (e.g., Echinocandins like Micafungin) based on susceptibility.

3. Hemodynamic monitoring and supportive care.

4. Repeat blood cultures until two consecutive negatives.

Regarding follow-up:

1. Daily clinical assessment.

2. Serial blood cultures until confirmed clearance of infection.

3. Monitoring for complications like endocarditis, deep-seated infection, and septic shock.

4. Long-term infectious disease follow-up after hospital discharge.

Preventive measures:

1. Strict aseptic technique during catheter insertion and care.

2. Early removal of unnecessary invasive lines.

3. Proper hand hygiene and infection control practices in the hospital setting.

I hope this helps.

Kindly follow up if you have more concerns.

Thank you.